Publisher
Springer Science and Business Media LLC
Subject
Genetics (clinical),Cardiology and Cardiovascular Medicine,Pharmaceutical Science,Genetics,Molecular Medicine
Reference41 articles.
1. Taupin, J.L., Pitard, V., Dechanet, J., Miossec, V., Gualde, N., & Moreau, J.F. (1998). Leukemia inhibitory factor: part of a large ingathering family. International Reviews of Immunology, 16(3–4), 397–426.
2. Rathjen, P.D., Toth, S., Willis, A., Heath, J.K., & Smith, A.G. (1990). Differentiation inhibiting activity is produced in matrix-associated and diffusible forms that are generated by alternate promoter usage. Cell, 62(6), 1105–1114.
3. Godard, A., Heymann, D., Raher, S., Anegon, I., Peyrat, M.A., Le Mauff, B., et al. (1992). High and low affinity receptors for human interleukin for DA cells/leukemia inhibitory factor on human cells. Molecular characterization and cellular distribution. The Journal of Biological Chemistry, 267(5), 3214–3222.
4. Fischer, P., & Hilfiker-Kleiner, D. (2008). Role of gp130-mediated signalling pathways in the heart and its impact on potential therapeutic aspects. British Journal of Pharmacology, 153 Suppl 1, S414–S427.
5. Yoshida, K., Taga, T., Saito, M., Suematsu, S., Kumanogoh, A., Tanaka, T., et al. (1996). Targeted disruption of gp130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematological disorders. Proceedings of the National Academy of Sciences of the United States of America, 93 (1), 407–411.
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献